LISPRO mitigates β-amyloid and associated pathologies in Alzheimer’s mice

Lithium has been marketed in the United States of America since the 1970s as a treatment for bipolar disorder. More recently, studies have shown that lithium can improve cognitive decline associated with Alzheimer’s disease (AD). However, the current United States Food and Drug Administration-approv...

Descripción completa

Detalles Bibliográficos
Autores principales: Habib, Ahsan, Sawmiller, Darrell, Li, Song, Xiang, Yang, Rongo, David, Tian, Jun, Hou, Huayan, Zeng, Jin, Smith, Adam, Fan, Shengnuo, Giunta, Brian, Mori, Takashi, Currier, Glenn, Shytle, Douglas Ronald, Tan, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520933/
https://www.ncbi.nlm.nih.gov/pubmed/28617434
http://dx.doi.org/10.1038/cddis.2017.279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520933/
https://www.ncbi.nlm.nih.gov/pubmed/28617434
http://dx.doi.org/10.1038/cddis.2017.279

Ejemplares similares